Long-acting Injectable Cabotegravir for PrEP Is Promising Dr Paul Sax discusses the interim results from a study on the use of the long-acting injectable cabotegravir for pre-exposure prophylaxis in ...
WTJX, our public television channel, aired “The Doctor Sax Story” on Jan. 25, 2017. This is to list the credits and cite contributors to the program: The panel of researchers and advisers who met ...
Most patients with multidrug-resistant HIV can still be treated with existing therapies, explained Paul Sax, MD, clinical director of the Division of Infectious Diseases at Brigham and Women's ...
♪ >> YOU’RE WATCHING WCVB NEWSCENTER 5 AT 5:30. ♪ ERIKA: THE U.S. COULD SEE 1,000 DEATHS PER DAY FROM COVID-19 THIS WINTER, IF THE RATE OF BOOSTER SHOTS DOES NOT IMPROVE. HERE TO ANSWER QUESTIONS IS ...
BOSTON (CBS) - Based on recommendations by the FDA and CDC, Massachusetts, New Hampshire, as well as federal vaccine programs at local pharmacies paused further injections of the Johnson & Johnson ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results